CoChat

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals

Open access

Published version of a preprint

Abstract

Fecal calprotectin is an established marker of gut inflammation in inflammatory bowel disease (IBD). Elevated levels of fecal calprotectin as well as gut microbial dysbiosis have also been observed in other clinical conditions. However, systemic and multi-omics alterations linked to elevated fecal calprotectin in older individuals remain unclear. This study comprehensively investigated the relationship between fecal calprotectin levels, gut microbiome composition, serum inflammation and targeted metabolomics markers, and relevant lifestyle and medical data in a large sample of older individuals (n = 735; mean age ± SD: 68.7 ± 6.3) from the TREND cohort study. Low (0–50 μg/g; n = 602), moderate (> 50–100 μg/g; n = 64) and high (> 100 μg/g; n = 62) fecal calprotectin groups were stratified. Several pro-inflammatory gut microbial genera were significantly increased and short-chain fatty acid producing genera were decreased in high vs. low calprotectin groups. In serum, IL-17C, CCL19 and the toxic metabolite indoxyl sulfate were increased in high vs. low fecal calprotectin groups. These changes were partially mediated by the gut microbiota. Moreover, the high fecal calprotectin group showed increased BMI and a higher disease prevalence of heart attack and obesity. Our findings contribute to the understanding of fecal calprotectin as a marker of gut dysbiosis and its broader systemic and clinical implications in older individuals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-024-63893-0

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Distribution of fecal calprotectin for different concentration intervals in the study population of older individuals (n = 735).
Figure 1 Distribution of fecal calprotectin for different concentration intervals in the study population of older individuals (n = 735).CC BY · PubMed Central
Figure 2 Genus-level differential abundance analysis. (a) Group-wise boxplots of the relative abundance (log2) of genera that show significant differences in group contrasts. (b) Significant (FDR-corrected, covariate-adjusted) findings of differential abundance of gut microbial genera for comparisons between moderate (> 50–100 μg/g) or high (> 100 μg/g) vs. low (≤ 50 μg/g) fecal calprotectin groups. The size of the markers corresponds to the base mean value (the mean of normalized counts of all samples) and the markers are color-coded based on group comparison. Bars indicate the standard error of log2-fold change. The phylum of the genera is indicated in brackets. P Proteobacteria, F Firmicutes.
Figure 2 Genus-level differential abundance analysis. (a) Group-wise boxplots of the relative abundance (log2) of genera that show significant differences in group contrasts. (b) Significant (FDR-corrected, covariate-adjusted) findings of differential abundance of gut microbial genera for comparisons between moderate (> 50–100 μg/g) or high (> 100 μg/g) vs. low (≤ 50 μg/g) fecal calprotectin groups. The size of the markers corresponds to the base mean value (the mean of normalized counts of all samples) and the markers are color-coded based on group comparison. Bars indicate the standard error of log2-fold change. The phylum of the genera is indicated in brackets. P Proteobacteria, F Firmicutes.CC BY · PubMed Central
Figure 3 Serum markers with significant differences between fecal calprotectin groups. (a) IL-17C, (b) CCL19 and (c) indoxyl sulfate were identified through multiple regression with potential confounders of fecal calprotectin included as covariates. The p-values have been FDR corrected for the number of 92 inflammation markers and 135 metabolites. Serum marker values were normalized and reported with arbitrary units. Red points indicate median values.
Figure 3 Serum markers with significant differences between fecal calprotectin groups. (a) IL-17C, (b) CCL19 and (c) indoxyl sulfate were identified through multiple regression with potential confounders of fecal calprotectin included as covariates. The p-values have been FDR corrected for the number of 92 inflammation markers and 135 metabolites. Serum marker values were normalized and reported with arbitrary units. Red points indicate median values.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 65 references

Cited by

See all 48

Metadata

Authors
Heinzel, S., Jureczek, J., Kainulainen, V., Nieminen, A. I., Suenkel, U., von Thaler, A.-K., Kaleta, C., Eschweiler, G. W., Brockmann, K., Aho, V. T. E., Auvinen, P., Maetzler, W., Berg, D., & Scheperjans, F.
Affiliations
  • Christian-Albrechts-Universität zu Kiel (DE)
  • University Hospital Schleswig-Holstein (DE)
  • University of Helsinki (FI)
  • Universitätsklinikum Tübingen (DE)
  • German Center for Neurodegenerative Diseases (DE)
Corresponding author
Heinzel, Sebastian
Venue
Scientific Reports
Published
2024-06-12
Volume
14
Issue
1
Pages
13513-13513
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4399576367
Cited by
36
References
65
Citations by year
2026: 17 · 2025: 18 · 2024: 1
FWCI
4.89
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Multimedialen Archiv und Publikationsserver der Christian-Albrechts-Universität zu Kiel (Christian-Albrechts-Universität zu Kiel) (submittedVersion, cc-by)
  • DZNE Pub (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Työväentutkimus Vuosikirja (submittedVersion)
Funders
  • Germany Research Society (675915)
  • Research Council of Finland (310835)
  • Universitätsklinikum Schleswig-Holstein - Campus Kiel
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
fecal calprotectin, gut dysbiosis, gut microbiota, older adults, IL-17C, CCL19, indoxyl sulfate, short-chain fatty acids, metabolomics, obesity, myocardial infarction
MeSH terms
Gastrointestinal Microbiome, Aged, Feces, Female, Humans, Male, Middle Aged, Inflammatory Bowel Diseases, Cohort Studies, Biomarkers, Leukocyte L1 Antigen Complex, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals. https://app.cochat.ai/papers/10.1038/s41598-024-63893-0
The paper
Heinzel, S., Jureczek, J., Kainulainen, V., Nieminen, A. I., Suenkel, U., von Thaler, A.-K., Kaleta, C., Eschweiler, G. W., Brockmann, K., Aho, V. T. E., Auvinen, P., Maetzler, W., Berg, D., & Scheperjans, F. (2024). Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals. Scientific Reports. https://doi.org/10.1038/s41598-024-63893-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.